Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stepan (SCL) EBT (2016 - 2025)

Stepan (SCL) has disclosed EBT for 16 consecutive years, with -$59.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 1120.17% year-over-year to -$59.3 million, compared with a TTM value of -$4.4 million through Dec 2025, down 108.23%, and an annual FY2025 reading of -$4.4 million, down 108.23% over the prior year.
  • EBT was -$59.3 million for Q4 2025 at Stepan, down from $16.5 million in the prior quarter.
  • Across five years, EBT topped out at $69.5 million in Q2 2022 and bottomed at -$72.6 million in Q4 2021.
  • Average EBT over 5 years is $18.2 million, with a median of $18.3 million recorded in 2024.
  • The sharpest move saw EBT soared 112.82% in 2022, then plummeted 1120.17% in 2025.
  • Year by year, EBT stood at -$72.6 million in 2021, then soared by 112.82% to $9.3 million in 2022, then tumbled by 139.37% to -$3.7 million in 2023, then tumbled by 32.65% to -$4.9 million in 2024, then tumbled by 1120.17% to -$59.3 million in 2025.
  • Business Quant data shows EBT for SCL at -$59.3 million in Q4 2025, $16.5 million in Q3 2025, and $13.8 million in Q2 2025.